Literature DB >> 17543949

Prostate cancer and race.

Otis W Brawley1, Ashesh B Jani, Veraj Master.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17543949     DOI： 10.1016/j.currproblcancer.2007.01.006

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN： 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  18 in total

1.  The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men.

Authors:  Michael Kongnyuy; Abhinav Sidana; Arvin K George; Akhil Muthigi; Amogh Iyer; Michele Fascelli; Meet Kadakia; Thomas P Frye; Richard Ho; Francesca Mertan; M Minhaj Siddiqui; Daniel Su; Maria J Merino; Baris Turkbey; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  Urol Oncol       Date:  2016-02-20       Impact factor: 3.498

2.  Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout life.

Authors:  Wan-yee Tang; Lisa M Morey; Yuk Yin Cheung; Lynn Birch; Gail S Prins; Shuk-mei Ho
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

3.  Analyzing the Association of Polymorphisms in the CRYBB2 Gene with Prostate Cancer Risk in African Americans.

Authors:  Mezbah U Faruque; Rabindra Paul; Luisel Ricks-Santi; Emmanuel Y Jingwi; Chiledum A Ahaghotu; Georgia M Dunston
Journal:  Anticancer Res       Date:  2015-05       Impact factor: 2.480

4.  Racial/Ethnic Disparities in Prostate Cancer Incidence, Distant Stage Diagnosis, and Mortality by U.S. Census Region and Age Group, 2012-2015.

Authors:  Siddharth Iyengar; Ingrid J Hall; Susan A Sabatino
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-17       Impact factor: 4.254

5.  Effect of CYP17 and PSA gene polymorphisms on prostate cancer risk and circulating PSA levels in the Slovak population.

Authors:  Monika Kmetová Sivoňová; Dušan Dobrota; Róbert Dušenka; Iveta Waczulíková; Peter Slezák; Tatiana Matáková; Silvia Mahmoodová; Dušan Mištuna; Ján Kliment
Journal:  Mol Biol Rep       Date:  2012-04-22       Impact factor: 2.316

6.  Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival.

Authors:  Vincent L Freeman; Ana C Ricardo; Richard T Campbell; Richard E Barrett; Richard B Warnecke
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-22       Impact factor: 4.254

7.  Evaluation of prostate cancer characteristics in four populations worldwide.

Authors:  Charnita M Zeigler-Johnson; Hanna Rennert; R Devi Mittal; Mohamed Jalloh; Rajeev Sachdeva; S Bruce Malkowicz; Anil Mandhani; B Mittal; Serigne M Gueye; Timothy R Rebbeck
Journal:  Can J Urol       Date:  2008-06       Impact factor: 1.344

8.  The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.

Authors:  Gabriel P Haas; Nicolas Delongchamps; Otis W Brawley; Ching Y Wang; Gustavo de la Roza
Journal:  Can J Urol       Date:  2008-02       Impact factor: 1.344

9.  Association of diabetes with prostate cancer risk in the multiethnic cohort.

Authors:  Kevin M Waters; Brian E Henderson; Daniel O Stram; Peggy Wan; Laurence N Kolonel; Christopher A Haiman
Journal:  Am J Epidemiol       Date:  2009-02-24       Impact factor: 4.897

10.  Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.

Authors:  Philip Rosen; David Pfister; Denise Young; Gyorgy Petrovics; Yongmei Chen; Jennifer Cullen; Diana Böhm; Sven Perner; Albert Dobi; David G McLeod; Isabell A Sesterhenn; Shiv Srivastava
Journal:  Urology       Date:  2012-08-28       Impact factor: 2.649
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.